This article provides an up-to-date comprehensive review and summary on neonatal polycystic kidney disease (PKD) with emphasis on the differential diagnosis, clinical manifestations, diagnostic techniques, and potential therapeutic approaches for the major causes of neonatal PKD, namely hereditary disease, including autosomal recessive and autosomal dominant PKD and nonhereditary PKD, with particular emphasis on multicystic dysplastic kidney. A brief overview of obstructive cystic dysplasia and simple and complex cysts is also included.
Effect of sodium chloride, enalapril, and losartan on the development of polycystic kidney disease in Han:SPRD rats
Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study
Morbidity from congenital hepatic fibrosis after renal transplantation for autosomal recessive polycystic kidney disease
Predictive factors of ultrasonographic involution of prenatally detected multicystic dysplastic kidney
Increasing detection rates of birth defects by prenatal ultrasound leading to apparent increasing prevalence. Lessons learned from the population-based registry of birth defects of Barcelona
Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD)
Multicystic dysplastic kidney with ipsilateral abnormalities of genitourinary tract: experience in children
Risk assessment of incidentally detected complex renal cysts in children: potential role for a modification of the Bosniak classification
Asymmetric development of tumor-like cysts in a child with autosomal dominant polycystic kidney disease
Unilateral multicystic dysplastic kidney: a meta-analysis of observational studies on the incidence, associated urinary tract malformations and the contralateral kidney
PKHD1 sequence variations in 78 children and adults with autosomal recessive polycystic kidney disease and congenital hepatic fibrosis.
Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study
Kidney and liver transplantation in patients with autosomal recessive polycystic kidney disease: a multicentric study
Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing.
Portal hypertension in children: expert pediatric opinion on the report of the Baveno v Consensus Workshop on Methodology of Diagnosis and Therapy in Portal Hypertension
An autopsy case of clinically un-diagnosed autosomal recessive polycystic kidney disease in 77-year-old male
New approaches to the autosomal recessive polycystic kidney disease patient with dual kidney-liver complications
A link between the intrarenal renin angiotensin system and hypertension in autosomal dominant polycystic kidney disease
Rationale and design of the DIPAK 1 study: a randomized controlled clinical trial assessing the efficacy of lanreotide to Halt disease progression in autosomal dominant polycystic kidney disease
Molecular diagnosis of autosomal dominant polycystic kidney disease using next-generation sequencing
Neonatal polycystic kidney disease, a potential life-threatening condition at this age: A case report
Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.
Bladder Carcinoma In Situ
Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.
Antihypertensive Agents: Mechanisms of Action
Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.
Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.